Pharmacy Benefit News,Information and Expert Analysis Keyword Search Benefit Design & Cost ManagementAdherenceChronic CareClinical ServicesFormularyPerformance ManagementDrug Trend ReportDTR 2019DTR 2021DTR 2022DTR 2024News & UpdatesCEO InsightsIndustry newsIndustry predictionsIndustry updatesLegislationNavitus in the newsNavitus updatesPartnership AnnouncementPress ReleasePublic HealthRegulatoryPBM 101Choosing a PBMDrug manufacturingHybrid modelNon-traditional pbmPass-through modelPBM ModelsTraditional pbmWebinarsPeople & CultureAnniversaryARG: Green TeamAssociate spotlightCEO InsightsDEIExecutive spotlightResourcesEmployer GroupHealth PlanMemberPharmacyPlan SponsorResearchResidentServices & SolutionsAdherenceFW&AMTMNavitus KeyRDURRISESTARSpecialtyBiosimilarsChronic CareFormularySpecialty Drug SpendSpecialty SpendSuccess StoriesCase StudiesClient experienceClinical excellenceMember experienceTrend PBM 101: Understanding Transparency for Better Pharmacy Benefits Read More Navitus Announces Navitus Key, a Best-in-Class PBM Solution for Employers with Less than 5,000 Members Read More Navitus Drug Trend Report: Keeping Costs Low for Plans and Members in an Era of Accelerating Inflation Read More Legal Ease: Key Legislative & Regulatory Updates Impacting Plan Sponsors in 2025 Read More Navigating the Drug Supply Chain: What You Need to Know Read More Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars Read More PBM 101: Why the Model Matters Read More Associate Resource Group Spotlight: Green Team Read More PBM 101: The Three PBM Business Models Read More An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM) Read More Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings Read More Pass-Through PBM Partnership Value Read More Page 1 of 2312345...Last »
